Imaging nanoscopic co-assemblies of α-synuclein and Tau in human samples
Open Access
- 18 September 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
α-synuclein (αS), amyloid-β (Aβ), and Tau aggregates are hallmarks of many neurodegenerative diseases, yet the prevalence and nature of their nanoscopic co-assemblies remain poorly understood. Here, we adapt a single-molecule pull-down (SiMPull) assay to profile αS, Aβ, and Tau co-assemblies across post-mortem brain tissue homogenates, soluble brain fractions, human serum, cerebrospinal fluid, and saliva. We show that αS–Tau co-assemblies are abundant across all sample matrices, accounting for ~10–70% of total αS aggregates in both Parkinson’s disease (PD) and control samples. Notably, αS–Tau co-assemblies in soluble brain fractions from controls exhibit higher Proteinase K (PK) resistance than those from PD cases. Biophysically, Tau accelerates αS aggregation in simple in vitro systems, but this effect is suppressed in complex environments. Together, this work establishes a framework for probing co-assemblies, revealing that αS–Tau species possess heterogeneous biophysical features and are unlikely to act as a single, uniformly toxic species in PD pathology.Keywords
Funding Information
- Royal Society (RSRP\R\210003)
This publication has 77 references indexed in Scilit:
- α‐Synuclein Drives Tau's Cytotoxic Aggregates Formation through Hydrophobic InteractionsChempluschem, 2023
- Truncation or proteolysis of α-synuclein in ParkinsonismAgeing Research Reviews, 2023
- Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformationsActa Neuropathologica, 2022
- Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegansBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2021
- Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer’s disease brainActa Neuropathologica, 2018
- Single‐molecule pull‐down (SiMPull) for new‐age biochemistryBioEssays, 2014
- Proteinase K-resistant α-synuclein is deposited in presynapses in human Lewy body disease and A53T α-synuclein transgenic miceActa Neuropathologica, 2010
- Interference of Heterophilic and Other Antibodies in Measurement of Therapeutic Drugs by Immunoassays2007
- Interaction between Aβ Peptide and α Synuclein: Molecular Mechanisms in Overlapping Pathology of Alzheimer’s and Parkinson’s in Dementia with Lewy Body DiseaseNeurochemical Research, 2006
- The effect of macromolecular crowding on protein aggregation and amyloid fibril formationJournal of Molecular Recognition, 2004